Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Masimo Corp
(NQ:
MASI
)
169.52
-0.27 (-0.16%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Masimo Corp
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
New Study Evaluates the Utility of Masimo ORi™ in Reducing Hyperoxemia During Laparoscopic Gastrectomy
February 21, 2023
From
Masimo
Via
Business Wire
Masimo Centroid® Receives Innovative Technology Designation from Vizient
February 15, 2023
From
Masimo
Via
Business Wire
Masimo to Report Fourth Quarter and FY 2022 Financial Results After Market Close on Tuesday, February 28
February 14, 2023
From
Masimo
Via
Business Wire
The Latest Analyst Ratings for Masimo
January 11, 2023
Via
Benzinga
Masimo's Return On Capital Employed Overview
December 06, 2022
Via
Benzinga
Expert Ratings for Masimo
December 05, 2022
Via
Benzinga
7 Analysts Have This to Say About Masimo
December 05, 2022
Via
Benzinga
Thoughts For Thursday: Risk-off, Risk-on
February 09, 2023
The one foot forward, one foot backward action continues on Wall Street, though yesterday it was more like three or four steps backward. It seems Q1 earnings jitters are responsible.
Via
Talk Markets
NeurAxis: Should You Buy This IPO?
February 08, 2023
As NeurAxis is ready to launch its IPO, we take a closer look to see if investors should be buying into the hype.
Via
Talk Markets
Masimo Announces the Limited Market Release of Visual Clinical Activity Monitoring (VCAM™)
January 30, 2023
From
Masimo
Via
Business Wire
Intuitive Surgical Stock Hits 80-Plus Relative Strength Rating Benchmark
January 23, 2023
On Monday, Intuitive Surgical stock had its Relative Strength (RS) Rating upgraded to 81, up from 73 a day earlier.
Via
Investor's Business Daily
InMode Stock Glowing Again As Cosmetic Surgery Market Recovers
January 23, 2023
The upwardly revised 75 RS Rating shows InMode stock outperformed 75% of all stocks over the past year. Its other ratings are even better.
Via
Investor's Business Daily
Researchers Harness the Power of Masimo Root®’s Advanced Multimodal Monitoring Capabilities to Study the Impact of Different Ventilatory Strategies on Brain Oxygenation During Thoracoscopic Surgery
January 23, 2023
From
Masimo
Via
Business Wire
Masimo and Philips Expand Partnership to Improve Telehealth for Patients and Clinicians Around the World with the Masimo W1™ Watch
January 18, 2023
From
Masimo
Via
Business Wire
How Masimo Is Taking On Electronics Giant Apple — And Winning
January 11, 2023
Apple could be on the hook for a royalty tied to its Apple Watch.
Via
Investor's Business Daily
Apple Watch Faces Potential Import Ban As US Judge Rules Against Tech Giant In Patent Infringement Case
January 10, 2023
Via
Benzinga
ITC Judge Rules Apple Violated U.S. Trade Laws by Infringing Masimo Pulse Oximeter Patent
January 10, 2023
From
Masimo
Via
Business Wire
New Study Evaluates the Performance of Masimo SpHb® Noninvasive Spot-Check Hemoglobin in the Emergency Department
January 09, 2023
From
Masimo
Via
Business Wire
New Study Finds That Masimo Patient SafetyNet™ Helped Clinicians Reduce CPR Events and Rates, Improve CPR Success Rate, and Reduce Hospital Length of Stay and Mortality
January 05, 2023
From
Masimo
Via
Business Wire
Masimo to Present in 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023
From
Masimo
Via
Business Wire
New Prospective Study Evaluates the Accuracy of Masimo SpHb® Noninvasive and Continuous Hemoglobin Monitoring During Elective Cesarean Section
January 03, 2023
From
Masimo
Via
Business Wire
$7.5 Million Bet On This Financial Services Stock? Check Out These 3 Stocks Insiders Are Buying
December 20, 2022
Although US stocks closed lower on Monday, there were a few notable insider trades.
Via
Benzinga
Masimo Takes Major Step in Connecting the Hospital to the Home
December 13, 2022
From
Masimo
Via
Business Wire
Masimo Hosts Investor Day to Detail Next Phase of Its Growth Trajectory
December 13, 2022
From
Masimo Corporation
Via
Business Wire
Masimo Announces Limited Market Release of Sepsis Index
December 12, 2022
From
Masimo
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
December 15, 2022
Via
Benzinga
Masimo Announces Full Market Release of Hydration Index for the Masimo W1™ Advanced Health Tracking Watch
December 07, 2022
From
Masimo
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 06, 2022
Gainers
Via
Benzinga
New Prospective Study Finds That Masimo SpHb® Noninvasive and Continuous Hemoglobin Monitoring Can Help Provide Effective Blood Management in Patients Undergoing Major Surgery
November 30, 2022
From
Masimo
Via
Business Wire
Masimo to Present in Piper Sandler 34th Annual Healthcare Conference
November 22, 2022
From
Masimo
Via
Business Wire
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.